Comparison of complication rates of Hickman® catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy

Ming Y. Lim, Aref Al-Kali, Aneel Arjun Ashrani, Kebede Begna, Michelle A. Elliott, William Hogan, C. Christopher Hook, Scott H Kaufmann, Louis Letendre, Mark R Litzow, Mrinal M Patnaik, Animesh D Pardanani, Ayalew Tefferi, Alexandra P. Wolanskyj, Diane E. Grill, Rajiv K. Pruthi

Research output: Contribution to journalArticle

20 Scopus citations


Central venous access devices (CVADs) are used for intravenous therapy in patients with hematological malignancies. There are limited data comparing catheter outcomes in patients with acute myeloid leukemia (AML) undergoing induction chemotherapy. A retrospective review comparing the incidence of early and late CVAD-associated complications and their effect on CVAD removal was performed in patients with AML undergoing induction chemotherapy between 2007 and 2011. Overall, 64 Hickman® catheters and 84 peripherally inserted central catheters (PICCs) were inserted. There was a trend toward increasing use of PICCs. The rate of CVAD occlusion was higher in PICCs compared to Hickman catheters (48.2% vs. 3.2%), for a rate of 20.43 vs. 1.25 per 1000 CVAD-days (p = 0.0001). There was no significant difference in the rates of CVAD-associated thrombosis, premature removal, blood stream infection (BSI) and CVAD-related BSI. Importantly, there was no significant difference in the rate of CVAD removal between Hickman catheters and PICCs for the duration that the CVADs were in place. The choice of type of CVAD inserted into patients with newly diagnosed AML will depend on ease of catheter placement, cost, perception of frequency and severity of complications, and clinician preference.

Original languageEnglish (US)
Pages (from-to)1263-1267
Number of pages5
JournalLeukemia and Lymphoma
Issue number6
StatePublished - Jun 2013



  • Acute myeloid leukemia
  • Complication rates
  • CVAD

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this